Development of Dl1.72, a novel anti-DLL1 antibody with anti-tumor efficacy against estrogen receptor-positive breast cancer

Gabriela Silva, Joana Sales-Dias, Diogo B. Casal, Sara Alves, Giacomo Domenici, Clara Barreto, Carolina Matos, Ana R. Lemos, Ana T. Matias, Khrystyna Kucheryava, Andreia Ferreira, Maria Raquel Moita, Sofia Braga, Catarina Brito, M. Guadalupe Cabral, Cristina Casalou, Duarte C. Barral, Pedro M. F. Sousa, Paula A. Videira, Tiago M. BandeirasAna Barbas

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
25 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Development of Dl1.72, a novel anti-DLL1 antibody with anti-tumor efficacy against estrogen receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences